In T2DM patients, after a meal, food reaches the gastrointestinal tract, stimulates the pancreas and promotes glucagon-like peptide-1 (GLP-1) inactivation under the catalysis action of dipeptide peptidase-IV (DPP-IV). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.